FindTrial
Sign In

A Randomized Comparative Study Between Dexmedetomidine 100 And Clonidine 150 As Adjuvant To Ropivacaine In Ultrasound Guided Adductor Canal Block For TKR Surgeries

A Randomized Comparative Study Between Dexmedetomidine And Clonidine As Adjuvant To Ropivacaine In Ultrasound Guided Adductor Canal Block For TKR Surgeries - TKR ACB

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036159
Enrollment
100
Registered
2021-09-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M171- Unilateral primary osteoarthritisof knee

Interventions

Control Intervention1: clonidine 150mcg: single dose during block. Control Intervention2: dexmedetomedine 100 mcg: single dose during block administration

Sponsors

Sanjay Gandhi Institute Of Trauma And Orthopedics
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)ASA I to III patients of either sex. 2)Undergoing unilateral total knee replacement surgeries.

Exclusion criteria

Exclusion criteria: 1)Patients with a history of allergy to local anesthetics. 2)Patients with history of mental dysfunction. 3)Patient refusal. 4)Morbid obesity, coagulopathy and significant cardiovascular, respiratory, renal, hepatic or metabolic disease or CNS disorders. 5)Infection at site of procedure.

Design outcomes

Primary

MeasureTime frame
1)Onset of sensory block 2)Duration of sensory blockade 3)Total rescue analgesia consumption in the first 24hrs. Timepoint: 1 day—

Secondary

MeasureTime frame
adverse reactions if anyTimepoint: 24 hrs—

Countries

India

Contacts

Public ContactDr Bharath Kumar K

Sanjay Gandhi Institute of Trauma and Orthopedics

drbharthkumar@gmail.com9620422424

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026